September 2007

Allen C. Ho, MD, to be Retina Today's Chief Medical Editor in 2008

ALAN B. GURALNICK, PUBLISHER

Comparing Anti-VEGF Therapies in Neovascular Age-Related Macular Degeneration

Some of the most promising new developments in the treatment of neovascular AMD have centered on targeting and inhibiting VEGF-A or its signaling pathways.

DAVID S. BOYER, MD

Surgery: A Viable Option for Treatment of Peripapillary CNV

Symptomatic PPCNVs are often large neovascular complexes that may lead to severe vision loss.

SABINE AISENBREY, MD

Examining the Effectiveness of Preoperative Topical Antibiotics

Knowing when to administer the antibiotic is important for the prevention and treatment of infectious ocular diseases.

LEAH D. FARR, ASSOCIATE EDITOR

Multiple VEGF-A Variants Linked to Severe DR in Patients With Type 1 Diabetes

Addressing the mechanisms by which VEGF-A variants exert effects on diabetic retinopathy should be a priority for further research.

ANDREW D. PATERSON, MD

Urokinase and Its Receptor: Novel Therapeutic Target in Diabetic Retinopathy

Proteinases may be a promising target for early therapeutic intervention in diabetic retinopathy.

DEEPTI NAVARATNA, PhD, AND ARUP DAS, MD

Outcomes From a DR Screening Study Implemented in Clinic, Community Settings

The objective of this study was to demonstrate the feasibility and outcomes of a telemetric screening program using nonmydriatic technology.

LAURA A. BETTENCOURT, MPH

Strong Relationship Found Between Retinopathy, Coronary Atherosclerosis

Patients enrolled in the Veterans Affairs Diabetes Trial were evaluated.

CONNI BERGMANN KOURY, EDITOR-IN-CHIEF

Genetic System Offers Option for Studying Role of Retinal Müller Cells

The function of VEGF in retinal neovascularization is widely acknowledged, but the role of retinal Müller cells in neovascularization has not been well investigated.

CONNI BERGMANN KOURY, EDITOR-IN-CHIEF

Fish Eyes Offer Clues to Curing Retinal Diseases

Cells may regenerate damaged retinas in humans.

G. ASTRID LIMB, PhD, BSc, MSc

Risk of Vision Loss Increased in Black Diabetes Patients

Type 1 diabetes patients included in the New Jersey 725 study were reexamined after 6 years.

LEAH D. FARR, ASSOCIATE EDITOR

Eye Care in the African American Community and Beyond

Many Americans at risk of vision loss do not have access to education or services.

LEAH D. FARR, ASSOCIATE EDITOR

Clinical Trial Update: Diabetic Eye Diseases

Trial: Study of Association of Serum Factors With Diabetic Retinopathy

Intravitreal Triamcinolone for the Treatment of Diabetic Macular Edema

Jointly sponsored by The Dulaney Foundation and Retina Today. Release Date: September 1, 2007. Expiration Date: October 31, 2008. This continuing medical education activity is supported by an educational grant from Genentech.

MICHAEL S. IP, MD

Robert Miller, MD

Dr. Miller discovered many neurocircuitry operations in the retina.

Robert Miller, MD